Phosphoinositide 3-Kinase Activation in Late G1 Is Required for c-Myc Stabilization and S Phase Entry
暂无分享,去创建一个
[1] Zaira García,et al. Phosphoinositide 3‐kinase controls early and late events in mammalian cell division , 2006, The EMBO journal.
[2] J. Walter,et al. Getting a grip on licensing: mechanism of stable Mcm2-7 loading onto replication origins. , 2006, Molecular cell.
[3] L. Penn,et al. Cancer therapeutics: targeting the dark side of Myc. , 2005, European journal of cancer.
[4] S. Lowe,et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants , 2005, Nature.
[5] J. Julian Blow,et al. Preventing re-replication of chromosomal DNA , 2005, Nature Reviews Molecular Cell Biology.
[6] C. Martínez-A,et al. Statins Inhibit HIV-1 Infection by Down-regulating Rho Activity , 2004, The Journal of experimental medicine.
[7] R. Medema,et al. Myc‐induced proliferation and transformation require Akt‐mediated phosphorylation of FoxO proteins , 2004, The EMBO journal.
[8] Bruce Stillman,et al. Deregulation of cyclin E in human cells interferes with prereplication complex assembly , 2004, The Journal of cell biology.
[9] Joseph R. Nevins,et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells , 2004, Nature Cell Biology.
[10] A. Carrera,et al. Control of Cyclin G2 mRNA Expression by Forkhead Transcription Factors: Novel Mechanism for Cell Cycle Control by Phosphoinositide 3-Kinase and Forkhead , 2004, Molecular and Cellular Biology.
[11] Yan Geng,et al. Cyclin E Ablation in the Mouse , 2003, Cell.
[12] A. Carrera,et al. Phosphoinositide 3-Kinase Activation Regulates Cell Division Time by Coordinated Control of Cell Mass and Cell Cycle Progression Rate* , 2003, Journal of Biological Chemistry.
[13] J. Sedivy,et al. Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point. , 2003, Molecular biology of the cell.
[14] A. Harwood,et al. The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle. , 2003, Progress in cell cycle research.
[15] E. Lam,et al. Cell Cycle Inhibition by FoxO Forkhead Transcription Factors Involves Downregulation of Cyclin D , 2002, Molecular and Cellular Biology.
[16] A. Carrera,et al. The p85 Regulatory Subunit Controls Sequential Activation of Phosphoinositide 3-Kinase by Tyr Kinases and Ras* , 2002, The Journal of Biological Chemistry.
[17] Stella Pelengaris,et al. c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.
[18] Carlos L. Arteaga,et al. PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization , 2002, Nature Medicine.
[19] Marielle Afanassieff,et al. Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells , 2002, Oncogene.
[20] R. Laskey,et al. Distinct roles for cyclins E and A during DNA replication complex assembly and activation , 2002, Nature Cell Biology.
[21] H. Nishitani,et al. Control of DNA replication licensing in a cell cycle , 2002, Genes to cells : devoted to molecular & cellular mechanisms.
[22] G. Panayotou,et al. Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit. , 2002, Cancer cell.
[23] D. Stacey,et al. Regulation of Ras signaling by the cell cycle. , 2002, Current opinion in genetics & development.
[24] C. Martínez-A,et al. Forkhead transcription factors contribute to execution of the mitotic programme in mammals , 2001, Nature.
[25] Andrius Kazlauskas,et al. Growth-factor-dependent mitogenesis requires two distinct phases of signalling , 2001, Nature Cell Biology.
[26] Bruce Stillman,et al. Chromatin Association of Human Origin Recognition Complex, Cdc6, and Minichromosome Maintenance Proteins during the Cell Cycle: Assembly of Prereplication Complexes in Late Mitosis , 2000, Molecular and Cellular Biology.
[27] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[28] R. Medema,et al. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 , 2000, Nature.
[29] R. Laskey,et al. The roles of the MCM, ORC, and Cdc6 proteins in determining the replication competence of chromatin in quiescent cells. , 2000, Journal of structural biology.
[30] Christopher C. Taylor,et al. Platelet-Derived Growth Factor Activates Porcine Thecal Cell Phosphatidylinositol-3-Kinase-Akt/PKB and Ras-Extracellular Signal-Regulated Kinase-1/2 Kinase Signaling Pathways via the Platelet-Derived Growth Factor-β Receptor. , 2000, Endocrinology.
[31] John M. Sedivy,et al. c-Myc Regulates Cyclin D-Cdk4 and -Cdk6 Activity but Affects Cell Cycle Progression at Multiple Independent Points , 1999, Molecular and Cellular Biology.
[32] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[33] Andrius Kazlauskas,et al. PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1 , 1999, Current Biology.
[34] Chi V. Dang,et al. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.
[35] A. Klippel,et al. Activation of Phosphatidylinositol 3-Kinase Is Sufficient for Cell Cycle Entry and Promotes Cellular Changes Characteristic of Oncogenic Transformation , 1998, Molecular and Cellular Biology.
[36] B. Burgering,et al. Essential Role for Protein Kinase B (PKB) in Insulin-induced Glycogen Synthase Kinase 3 Inactivation , 1998, The Journal of Biological Chemistry.
[37] W. Evans,et al. In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[38] B. Amati,et al. Myc and the cell cycle. , 1998, Frontiers in bioscience : a journal and virtual library.
[39] J. Sedivy,et al. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[40] Andreas Sewing,et al. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes , 1997, Oncogene.
[41] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[42] B. Amati,et al. Growth arrest by the cyclin‐dependent kinase inhibitor p27Kip1 is abrogated by c‐Myc. , 1996, The EMBO journal.
[43] G. Evan,et al. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.